## Efficacy Analysis Evaluation

**Section:** efficacy_analysis
**Rating:** GREAT
**Status:** pass

---

### Extraction Validation

- **sections read:** 8.1, 4.9
- **elements per section:** component_name: 1
- **elements extracted:** 3
- **elements in evaluation table:** 3
- **elements in missing from generated SAP:** 0
- **counts match:** True

---

### Evaluation Table (3 items)

#### 1. Endpoint Name

- **evaluation type:** exact_match
- **original SAP text:** ORR based on BOR during the Induction Study Period
- **generated SAP text:** Objective response rate (ORR, %) based on BOR during the Induction Study Period by RECIST v.1.1
- **protocol text:** objective response rate (ORR) up to Cycle 6 during the Induction Study Period
- **protocol consulted:** yes
- **matches original SAP:** yes
- **detail level:** match
- **omitted content:** none
- **omission impact:** none
- **result:** correct
- **issue type:** none
- **severity:** none
- **reasoning:** The Generated SAP correctly identifies the primary endpoint name, matching the Original SAP and Protocol.

#### 2. Endpoint Definition

- **evaluation type:** semantic
- **original SAP text:** The ORR is defined as the proportion of patients with a confirmed BOR of CR or PR (the ‘responder’). All other patients in the ITT or PP population except responders will be considered as non-responder including patients without post-baseline tumor assessment. ... Missing values in ORR will be considered as ‘Non-responder’
- **generated SAP text:** defined as the proportion of patients achieving a Best Overall Response (BOR) of either Complete Response (CR) or Partial Response (PR) during the Induction Study Period (up to Cycle 6)... Patients with no post-baseline tumor assessment or whose response cannot be evaluated (NE) will be treated as non-responders
- **protocol text:** Objective response rate (ORR, %) based on BOR during the Induction Study Period by RECIST v.1.1
- **protocol consulted:** yes
- **matches original SAP:** yes
- **detail level:** match
- **omitted content:** none
- **omission impact:** none
- **result:** correct
- **issue type:** none
- **severity:** none
- **reasoning:** The definition in the Generated SAP accurately reflects the Original SAP, including the handling of non-responders and missing data.

#### 3. Analysis Method

- **evaluation type:** semantic
- **original SAP text:** The similarity criterion has been set such that the confidence limits of the 95% CI of the difference in ORR from each treatment group will be entirely bounded by the interval (-12.5, 12.5). The primary analysis for the primary endpoint will be performed utilizing a logistic regression model considering country, sex (female vs. male), disease status at baseline (recurrence vs. metastatic), and ECOG performance status at baseline (0 vs. 1) as covariates with treatment groups (CT-P16 and EU-Approved Avastin) as a fixed effect. Country can be pooled into region (EMEA vs. America vs. Asia) for statistical analysis when there are not enough patients within each country. ... The Delta Method for estimating difference of proportion is explained... Tipping point analysis will also be conducted using central review data based on exact binomial approach in the ITT population for a sensitivity analysis.
- **generated SAP text:** The primary analysis will compare the ORR between the CT-P16 and EU-Approved Avastin groups... Equivalence will be assessed using a logistic regression model... Covariates will include the stratification factors: sex... disease status... and ECOG... Country will be included... pooled by region... The resulting odds ratio and its 95% confidence interval (CI) will be converted into a difference in proportions... using the Delta method. ... Therapeutic similarity will be concluded if the 2-sided 95% CI for the difference in ORR is entirely contained within the equivalence margin of (-12.5%, 12.5%).
- **protocol text:** The similarity criterion has been set such that the confidence limits of the 95% CI of the difference in ORR will be entirely bounded by the interval (-12.5, 12.5). The primary analysis for the primary endpoint will be performed utilizing a logistic regression model considering covariates with treatment groups... as a fixed effect... The resulting odds ratio and 95% CI will be converted into difference of proportions using the Delta method
- **protocol consulted:** yes
- **matches original SAP:** yes
- **detail level:** less_detailed
- **omitted content:** Tipping point analysis; specific region definitions (EMEA vs America vs Asia)
- **omission impact:** none
- **result:** acceptable
- **issue type:** none
- **severity:** none
- **reasoning:** The Generated SAP correctly captures the primary statistical model (logistic regression), covariates, Delta method, and equivalence margins. It omits the 'Tipping point analysis' and the specific region names (EMEA/America/Asia), but neither of these details is present in the Protocol, making their omission acceptable.

---

### Issues Found (0 items)

*No issues found.*

---

### Extra Information Flagged (1 items)

#### 1. Specific sensitivity analyses (Complete Case, Confirmed vs Unconfirmed, Alternative Covariate)

- **content:** Specific sensitivity analyses (Complete Case, Confirmed vs Unconfirmed, Alternative Covariate)
- **generated SAP text:** Sensitivity Analysis/Analyses... Complete Case Analysis... Confirmed vs. Unconfirmed Response... Alternative Covariate Adjustment
- **contradicts:** no
- **detail:** The Generated SAP lists specific sensitivity analyses not explicitly detailed in the Original SAP (which only specifies Tipping Point and Local Review). However, the Original SAP allows for 'Sensitivity analyses... using imputation or excluding outliers', so these additions are not contradictions.
- **reasoning:** The Generated SAP includes standard sensitivity analyses that are not explicitly mandated in the Original SAP but do not contradict the general allowance for sensitivity analyses.

---

### Missing from Generated SAP (0 items)

*No missing from generated sap.*

---

### Reasoning

The Generated SAP accurately captures the primary efficacy endpoint (ORR), its definition, and the primary analysis methodology (logistic regression, covariates, Delta method, equivalence margins). It omits the 'Tipping point analysis' and specific region definitions found in the Original SAP, but since these are not present in the Protocol, their omission is acceptable. The Generated SAP also includes some standard sensitivity analyses not explicitly in the Original SAP, which is flagged as extra information but does not negatively impact the rating.

---

### Summary

The Generated SAP provides a high-quality representation of the primary efficacy endpoint and its analysis. The primary statistical model and decision criteria match the Original SAP perfectly. Minor omissions regarding specific sensitivity analyses and region definitions are acceptable as they are not required by the Protocol.